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Translation, linguistic and cultural adaptation, 
reliability and validity of the Radboud Oral 
Motor Inventory for Parkinson’s Disease – 
ROMP questionnaire
Tradução, adaptação linguística e cultural, confiabilidade e validade do questionário 
“Radboud Inventário Motor Oral para doença de Parkinson – ROMP”
Monia Presotto1, Maira Rozenfeld Olchik2, Johanna G. Kalf3, Carlos R.M. Rieder4,5
Parkinson’s disease (PD) is a chronic and progressive con-
dition of the nervous system, characterized by the cardinal 
signs of rigidity, bradykinesia, tremor and postural instabil-
ity1. Other clinical data of importance are: gait disturbances, 
mask facies, dysarthria, drooling, sexual dysfunction, cramps, 
pain, paresthesia, dysphagia, urinary incontinence, intestinal 
constipation, writing disorders (micrography), sleep distur-
bances, bradyphrenia, depression, and dementia2.
Studies show that up to 90% of people with PD may 
present with speech abnormalities, including defects that 
encompass the resonance, breathing, voice, and articula-
tion systems, considered to originate from motor planning 
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ABSTRACT
Objective: To translate and linguistically and culturally adapt to Brazilian Portuguese, and verify the reliability and validity of the 
Radboud Oral Motor Inventory for Parkinson’s Disease (ROMP). Methods: The ROMP was translated and retranslated, and the instrument 
reliability was verified by analyzing the internal consistency and the reproducibility of the intra-examiner retest. The final version was 
applied to 27 participants with Parkinson’s disease. Results: Internal consistency was 0.99 for the total ROMP and 0.96 to 0.99 for the 
three domains. Intraclass correlation coefficients for reproducibility were 0.99 for the total ROMP and 0.93 to 0.99 for the subscales. The 
ROMP and its subscales correlated substantially with the Likert-type scale, as well as with the unified Parkinson’s disease rating scale 
II and III items. Conclusion: The linguistic and cultural equivalence of the ROMP in Brazilian Portuguese is now available, with excellent 
reliability and validity.
Keywords: swallowing disorders; dysarthria; speech; Parkinson’s disease; surveys and questionnaires; rehabilitation; sialorrhea.
RESUMO
Objetivo: Traduzir e adaptar linguística e culturalmente para o português brasileiro, verificar a confiabilidade e a validade do Radboud 
Inventário Motor Oral para Doença de Parkinson (ROMP). Métodos: O ROMP foi traduzido e retraduzido, e a confiabilidade do instrumento 
foi verificada através da análise da consistência interna e da reprodutibilidade do reteste intra-examinador, sendo a versão final aplicada 
em 27 participantes com doença de Parkinson (DP). Resultados: A consistência interna foi de 0,99 para o ROMP total e de 0,96 a 0,99 
para os 3 domínios. Os coeficientes de correlação intra-classe para reprodutibilidade foram 0,99 para o ROMP total e 0,93 a 0,99 para 
as subescalas. O ROMP e suas subescalas correlacionaram-se substancialmente com a escala do tipo Likert, bem como com os itens 
UPDRS II e III. Conclusão: A equivalência linguística e cultural do ROMP no português brasileiro está agora disponível, com excelente 
confiabilidade e validade.
Palavras-chave: transtornos de deglutição; disartria; fala; doença de Parkinson; inquéritos e questionários; reabilitação; sialorreia.
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damage and difficulties in the execution of simultaneous or 
sequential characteristics of dysfunctions of the nuclei of the 
base3,4. The prevalence of dysphagia in PD patients ranges 
from 35-100% depending on the assessment, and subjective 
dysphagia occurs in one-third of community-dwelling PD 
patients. Objectively measured, dysphagia rates were much 
higher, with four out of five patients being affected. This sug-
gests that dysphagia is common in PD, but patients do not 
always report swallowing difficulties unless asked, and dys-
phagia in the first five years of the disease is considered a red 
flag for the diagnosis of PD5,6,7,8,9,10,11. Drooling is reported by 
about a quarter of the population, depending on the diagnos-
tic criteria12.
It is important to highlight the value of instruments to 
identify and quantify dysarthria, dysphagia, and drooling in 
patients with neurodegenerative diseases. These question-
naires will allow adequate referrals to be made when the 
symptom is still in its initial stages, minimizing the negative 
impact on the individual and, consequently, improving the 
quality of life of these patients.
Few questionnaires are validated to self-assess speech 
changes, swallowing disorders, and saliva disorders in PD 
patients and existing surveys are lengthy or do not suffi-
ciently specify all changes, such as the Swal-QOL for the sub-
jective assessment of dysphagia13,14.
Also, the few validated instruments are only available in 
their native language, mostly English. Of the tools researched 
and found in the present review, only one, the Radboud Oral 
Motor Inventory for Parkinson’s disease (ROMP) refers to the 
population with PD, which is published in the English trans-
lation of its original Dutch form12.
The ROMP was conceptually developed for the 
self-assessment of speech, swallowing and saliva control 
in patients with PD and atypical parkinsonism. In its origi-
nal form, it is a valid and reliable questionnaire for clinical 
and scientific use, providing useful information for clinical 
evaluation in this population. The authors of the question-
naire have reported that the influence of cognitive deterio-
ration on speech skills or the consequences of dysphagia 
was not included in generic questionnaires15,16. Therefore, 
they developed this survey to evaluate the three domains 
of speech, swallowing, and control of saliva. They created 
the ROMP in such way that it detected the symptoms at the 
levels of their functioning and activities, according to the 
International Classification of Functioning, Disability, and 
Health, while limiting the number of items. To compensate 
for cognitive problems, they constructed the responses in a 
way that the core of each item was repeated in the possibil-
ity of response14.
Therefore, with the authorization of the authors, this 
research aimed to carry out the translation, linguistic and cul-
tural adaptation, and reliability of the Brazilian version of the 
ROMP. In addition to validating the ROMP and its subscales 
against a Likert-type scale, the subscales of speech, salivation 
and swallowing of the Unified Parkinson’s Disease Rating 
Scale (UPDRS) II and the speech subscale of the UPDRS III.
METHODS
The research was approved by the Research Ethics 
Committee of the Hospital das Clínicas of Porto Alegre under 
number 150339, and the individuals who agreed to partici-
pate in the study signed the informed consent form.
The ROMP is a self-evaluative protocol in three domains: 
speech, swallowing and saliva. It consists of 23 items, seven 
items in the speech domain, seven items for swallowing and 
nine items relating to saliva. The patient marks the frequency 
of symptoms from 1-5 (1 = normal; 5 = worst score). The mini-
mum total score is 23, and the maximum score is 115 points.
Content validation (translation, linguistic and cultural 
adaptation), as well as the ROMP reliability, were carried out 
in the following steps:
1)  Translation and linguistic and cultural adaptation: the 
ROMP was translated, adapted and validated in its content, 
according to Beaton et al.17. Initially, it was translated from 
English into Brazilian Portuguese by two Brazilian profes-
sionals fluent in both languages, one of whom had specific 
knowledge and the other without specific knowledge of the 
project. Each of the translators performed the translation 
separately. Afterward, they analyzed any small discrepancies 
and, in consensus, the English version of the questionnaire 
was produced. Subsequently, back-translation to Brazilian 
Portuguese was done by two different English translators, 
without specific knowledge, also fluent in both languages, 
resulting in two versions of back translation. Both transla-
tions were analyzed by a committee of five specialists, three 
speech therapists and two neurologists, who evaluated the 
semantic, idiomatic, experimental and conceptual equiva-
lence, resulting in the final version.
2) Protocol application: the final protocol was then 
applied to 27 patients with idiopathic PD, who underwent 
clinical follow-up at the Movement Disorders outpatient 
clinic of the Hospital das Clínicas of Porto Alegre, RS, Brazil, 
between August 2015 and June 2016. Patients with a medi-
cal diagnosis of idiopathic PD according to the criteria of the 
London Brain Bank18, were at stage 2 or 3 on the Hoehn & 
Yahr (H&Y) scale19, and were using medication for the dis-
ease. Patients who had altered oral comprehension, auditory 
or visual impairment that made it impossible to perform the 
tasks, those who were off in relation to the medication at the 
time of the evaluation and those who refused to participate in 
the study were excluded. The need for a sample of 21 patients 
was initially estimated to detect a difference of 0.5 effect size, 
with a power of 80% and a level of significance of 5%20.
3) Reliability: quantifies the internal consistency between 
the items of the protocol and the intra-examiner reproduc-
ibility. Cronbach’s alpha (α) was used to quantify the internal 
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consistency. Intra-examiner reliability is the measure of repro-
ducibility of the evaluation by the same evaluator, during the 
repetition of the evaluation (test-retest)21,22. The retest was 
applied after two weeks to reduce the chances of modifica-
tion of the questionnaire responses, due to possible changes in 
the oral motor symptoms and to prevent the individual from 
remembering the protocol questions23. The reproducibility was 
calculated with intraclass correlation coefficients (ICC).
4) Validity: correlation between the ROMP and a Likert-
type scale. To verify this correlation, participants were 
asked to classify their speech, swallowing and saliva using 
a five-point Likert-type scale (self-perceptive): very good, 
good, reasonable, poor, very bad. Data were compared by 
Spearman’s correlation (r). It is worth mentioning that the 
self-perception analysis is a strategy commonly used to vali-
date self-assessment protocols in general24,25,26,27. Correlation 
between ROMP and UPDRS II and UPDRS III28. To verify this 
correlation, ROMP was compared with the subscales speech, 
salivation and swallowing of the UPDRS II and the subscale 
speech of the UPDRS III. Data were compared by Spearman’s 
correlation. The qualified professional applying the UPDRS 
was blinded for the scores of the ROMP and the scale was 
performed on the same day.
Statistics
The internal consistency was calculated with Cronbach’s α 
where we accepted 0.70 as a minimum for sufficient consis-
tency29. The test-retest reliability was calculated with ICCs and 
the correlation index 0.75 was considered the minimum 
acceptable agreement, since values  from 0.90 were considered 
high30. The validity of the ROMP against concurrent measures 
was expressed using Spearman’s correlation. The level of signif-
icance adopted was p ≤ 0.01 and the analyses were performed 
in the Statistical Package for Social Sciences version 20.0.
RESULTS
Demographic and clinical characteristics of 
patients with PD
Twenty-seven patients with PD (59.3% women) were 
evaluated. Data on the demographic variables of the partici-
pants are shown in Table 1.
Final version of the ROMP
The final composition of the ROMP (Figure), after trans-
lation, linguistic and cultural adaptation, has 23 self-assess-
ment questions, seven of which are questions on the speech 
domain, seven questions are about the swallowing domain 
and nine questions are in the saliva domain. The patient 
marks the frequency of symptoms from 1-5 (1 = normal; 
5 = worst score), as in the original.
Table 1. Demographic and clinical characteristics.
Variables Mean (SD)
Age (years) 64.9 (± 11.7)
Schooling (years) 6.6 (± 5.1)
Disease duration (years) 8.8 (± 7.1)
SD: standard deviation.
RADBOUD INVENTÁRIO MOTOR ORAL PARA DOENÇA DE PARKINSON - ROMP
ROMP- FALA
I. Atualmente, minha voz é:
1. Minha voz é normal.
2. Minha voz é um pouco mais fraca ou mais rouca do que costumava ser.
3. Minha voz é claramente mais fraca ou mais rouca.
4. Minha voz é muito fraca ou muito rouca.
5. Minha voz dificilmente é ouvida.
II. Minha capacidade para falar com pessoas familiares:
1. Pessoas familiares me acham inteligível/compreensível como sempre; eu não tenho que repetir.
2. Para pessoas familiares, às vezes eu sou menos inteligível/compreensível quando estou cansado ou não presto atenção.
3. Para pessoas familiares, frequentemente eu sou menos inteligível/compreensível; eu tenho que repetir muitas vezes.
4. Para pessoas familiares, muito frequentemente eu sou ininteligível/incompreensível, especialmente quando estou cansado.
5. Para pessoas familiares, geralmente eu sou ininteligível/incompreensível também quando repito.
III. Minha capacidade de para falar com pessoas desconhecidas:
1. Pessoas desconhecidas me acham inteligível/compreensível como sempre; eu não tenho que repetir.
2. Pessoas desconhecidas, às vezes eu sou menos inteligível/compreensível quando estou cansado ou não presto atenção.
3. Pessoas desconhecidas, frequentemente eu sou menos inteligível/compreensível; eu tenho que repetir muitas vezes.
4. Para pessoas desconhecidas, muito frequentemente eu sou ininteligível/ incompreensível, especialmente quando estou cansado.
5. Para pessoas desconhecidas, geralmente eu sou ininteligível/incompreensível, também quando repito.
Figure. Radboud Oral Motor Inventory for Parkinson’s Disease – ROMP. (Continue)
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IV. O uso do meu telefone:
1. Usar o telefone não é nenhum problema para mim.
2. Eu uso o telefone como eu costumava fazer, mas eu preciso prestar mais atenção do que antes.
3. Eu tenho que repetir várias vezes quando estou no telefone.
4. Eu fico relutante em usar o telefone porque as pessoas não me entendem.
5. Usar o telefone é impossível para mim porque minha fala é inadequada.
V. Quando começo a falar:
1. Eu consigo dizer o que eu quero tão facilmente como eu costumava fazer.
2. Às vezes eu preciso pensar um pouco mais do que eu costumava.
3. Eu preciso de mais tempo ou esqueço facilmente o que eu queria dizer.
4. Eu preciso de ajuda para formular meus pensamentos.
5. Eu geralmente não sei o que dizer e prefiro ficar em silêncio.
VI. Conversando em um grupo
1. Eu consigo participar em conversas como sempre.
2. Eu consigo participar em conversas, mas preciso prestar mais atenção.
3. Eu consigo participar em conversas apenas quando os outros levam em conta que eu preciso de mais tempo.
4. Eu consigo participar em conversas apenas quando pessoas familiares me ajudam.
5. Eu me sinto excluída porque não consigo participar.
VII. O quanto você se sente incomodado devido a sua dificuldade de falar?
1. Eu não tenho dificuldade para falar.
2. Minha dificuldade para falar me incomoda um pouco.
3. Eu me incomodo com minha dificuldade para falar, mas não é minha principal preocupação.
4. Minha dificuldade para falar me incomoda muito porque é muito limitante.
5. A dificuldade para falar é o pior aspecto da minha doença.
ROMP - DEGLUTIÇÃO
I. Quantas vezes você se engasga quando está comendo ou bebendo?
1. Eu nunca me engasgo ou não me engasgo mais que o costume.
2. Eu me engasgo cerca de uma vez por semana.
3. Eu me engasgo quase diariamente.
4. Eu me engasgo cerca de 3 vezes por dia ou durante cada refeição.
5. Eu me engasgo mais que 3 vezes por dia ou várias vezes durante as refeições.
II. Você fica limitado durante a ingestão de líquidos?
1. Eu consigo beber líquidos tão facilmente quanto eu costumava fazer.
2. Eu consigo beber líquidos facilmente, mas eu me engasgo um pouco mais fácil que costumava.
3. Eu consigo beber com segurança somente quando me concentro nisso.
4. Para beber com segurança, eu preciso usar um copo ou uma técnica especial.
5. Eu consigo beber com segurança somente quando ingiro líquidos. Espessados (engrossados).
III. Você fica limitado durante a alimentação?
1. Eu consigo comer tão facilmente quanto eu costumava fazer.
2. Eu consigo comer de tudo, mas demoro mais tempo do que antes.
3. Eu preciso evitar alimentos sólidos ou duros (carne, amendoins, etc).
4. Eu consigo comer somente alimentos macios ou fáceis de mastigar.
5. Eu preciso usar alimentação suplementar ou por via não oral.
II. Você tem dificuldade para engolir comprimidos?
1. Eu engulo comprimidos como eu costumava fazer.
2. Eu tenho um pouco mais de dificuldade para engolir comprimidos do que costumava.
3. Eu consigo engolir comprimidos somente com alimento cremoso junto ou usando uma técnica específica.
4. Engolir comprimidos é um grande esforço atualmente.
5. Eu não consigo mais engolir comprimidos e preciso de outra maneira para tomar a medicação.
V. Sua dificuldade de engolir limita sua refeição com outras pessoas?
1. Comer com os outros não é um problema pra mim.
2. Eu como e bebo com os outros, mas eu preciso tomar cuidado devido a minha dificuldade de engolir.
3. Eu prefiro comer na presença de pessoas conhecidas em locais familiares.
4. Eu como somente em casa e na presença de pessoas conhecidas.
5. Eu consigo comer somente em casa e com a ajuda de um cuidador.
Figure. Radboud Oral Motor Inventory for Parkinson’s Disease – ROMP. (Continue)
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VI. Você se preocupa com a sua dificuldade de engolir?
1. Eu não tenho dificuldade de engolir.
2. Eu tenho alguma dificuldade de engolir, mas não estou preocupado com isso.
3. Eu me preocupo um pouco com minha dificuldade de engolir.
4. Eu tenho ficado mais preocupado com minha dificuldade de engolir.
5. Eu estou muito preocupado com minha dificuldade de engolir.
VII. O quanto você se sente incomodado devido a sua dificuldade de engolir?
1. Eu não tenho dificuldade de engolir
2. Minha dificuldade de engolir me incomoda um pouco.
3. Eu me incomodo com minha dificuldade de engolir, mas não é minha principal preocupação.
4. Minha dificuldade de engolir me incomoda bastante porque é muito limitante.
5. Minha dificuldade de engolir é o pior aspecto da minha doença.
ROMP – SALIVA
I. Você tem perda de saliva durante o dia?
1. Eu não perco saliva durante o dia e não sinto acúmulo de saliva na minha boca.
2. Eu não perco saliva, mas eu sinto acúmulo de saliva na minha boca.
3. Eu perco saliva nos cantos da boca ou no queixo.
4. Eu perco saliva na minha roupa.
5. Eu perco saliva na minha roupa e também em cima de livros ou no chão.
II. Com que frequência você tem aumento de quantidade ou perda de saliva?
1. Menos de uma vez por dia.
2. Ocasionalmente: em média uma ou duas vezes por dia.
3. Frequentemente: 2 a 5 vezes por dia.
4. Muito frequentemente: 6 a 10 vezes por dia.
5. Quase constantemente.
III. Você tem perda de saliva durante a noite?
1. Eu não tenho perda de saliva durante a noite.
2. Às vezes meu travesseiro fica molhado durante a noite.
3. Meu travesseiro frequentemente fica molhado durante a noite.
4. Meu travesseiro sempre fica molhado durante a noite.
5. Todas as noites meu travesseiro e a roupa de cama ficam molhados.
IV. A sua (perda de) saliva o prejudica no comer e beber?
1. Não, minha perda de saliva não me prejudica ao comer e beber.
2. Sim, minha perda de saliva ocasionalmente me prejudica ao comer e beber.
3. Sim, minha perda de saliva frequentemente me prejudica ao comer e beber.
4. Sim, minha perda de saliva muito frequentemente me prejudica ao comer e beber.
5. Sim, minha perda de saliva sempre me prejudica ao comer e beber.
V. A sua perda de saliva prejudica sua fala?
1. Não, minha perda de saliva não prejudica minha fala.
2. Sim, minha perda de saliva ocasionalmente prejudica minha fala.
3. Sim, minha perda de saliva frequentemente prejudica minha fala.
4. Sim, minha perda de saliva muito frequentemente prejudica minha fala.
5. Sim, minha perda de saliva sempre prejudica minha fala.
VI. O que você precisa fazer para remover a saliva
1. Eu não preciso remover saliva.
2. Eu sempre carrego um lenço para remover possível saliva.
3. Diariamente, eu uso 1 ou 2 lenços para remover saliva.
4. Diariamente, eu preciso mais de 2 lenços para remover saliva.
5. Eu preciso remover saliva tão frequentemente que eu sempre tenho lenços por perto ou uso uma toalha para proteger minhas roupas.
VII. Sua perda de saliva limita seu contato com outras pessoas?
1. Minha perda de saliva não limita meu contato com outras pessoas.
2. Eu preciso prestar atenção, mas isso não me incomoda.
3. Eu preciso prestar mais atenção porque eu sei que os outros podem ver minha saliva escorrendo.
4. Eu tento evitar contato quando eu sei que perco saliva.
5. Eu percebo que os outros evitam ter contato comigo porque eu perco saliva.
Figure. Radboud Oral Motor Inventory for Parkinson’s Disease – ROMP. (Continue)
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Participants answered all questions. In the process of linguistic 
and cultural translation and adaptation, there was no elimination 
of any question, but conceptual adjustments were made, modify-
ing apple puree for creamy food and adding the terms comprehen-
sible with intelligible and incomprehensible with unintelligible.
Test-retest scores, mean, and standard deviation
The scores, means and the standard deviation for speech, 
swallowing and saliva are described in Table 2.
Reliability
Internal consistency of the three domains and total - 
Cronbach’s α
The value of Cronbach’s α for the total scores and the 
three subdomains of the instrument were above 0.96, indi-
cating that the ROMP had excellent internal consistency, 
as shown Table 3. 
Reproducibility of the three domains and total - ICC 
Table 4 shows the ICC values. The ICC of the total score 
and of the three subdomains ranged from 0.93 to 0.99 indicat-
ing a high level of agreement in the test-retest.
Spearman’s correlation between the ROMP and 
Likert-type scale
Spearman’s correlation between the three domains of the 
ROMP and the Likert-type scale was significant, according to 
the following results: the correlation coefficient of the subscale 
of speech was 0.73 (p = 0.00), the correlation coefficient of the 
subscale of swallowing was 0.59 (p = 0.01), and the correlation 
coefficient of the subscale of saliva control was 0.67 (p = 0.00).
Spearman’s correlation between the ROMP and 
UPDRS II 
Spearman’s correlation between the three domains 
of the ROMP and the corresponding subscales of the 
UPDRS II was also statistically significant, with the fol-
lowing results: the correlation coefficient of the subscale 
of speech was 0.52 (p = 0.00), the correlation coefficient of 
the subscale of salivation was 0.81 (p = 0.00), and the cor-
relation coefficient of the subscale of swallowing was 0.84 
(p = 0.00).
Spearman’s correlation between the ROMP and 
UPDRS III 
Spearman’s correlation between the ROMP speech 
self-evaluation domain and the subscale of speech of the 
UPDRS III was 0.64 (p = 0.00), and therefore, substantial.
VIII. Sua perda de saliva limita suas atividades dentro ou fora de casa?
1. Minha perda de saliva não limita minhas atividades.
2. Eu preciso prestar atenção quando estou ocupado, mas isso não me incomoda
3. Eu preciso prestar mais atenção, o que é trabalhoso.
4. Minha perda de saliva me limita em ser ativo.
5. Devido a minha perda de saliva, atividades importantes não são mais possíveis para mim.
IX. O quanto incomodado você fica como resultado da sua perda de saliva?
1. Eu dificilmente percebo perda de saliva.
2. Sentir ou perder saliva me incomoda um pouco.
3. Eu me incomodo com a minha perda de saliva, mas não é minha principal preocupação.
4. Minha perda de saliva me incomoda bastante porque é muito limitante.
5. Perder saliva é o pior aspecto da minha doença.
Figure. Radboud Oral Motor Inventory for Parkinson’s Disease – ROMP.




Test score 15.8 (± 7.0)
Retest score 15. 9 (± 7.0)
Swallowing
Test score 14. 6 (± 6.7)
Retest score 14.5 (± 6.6)
Saliva
Test score 13.6 (± 6.1)
Retest score 14.3 (± 6.7)
Total
Test score 43.2 (± 16.6)
Retest score 43.3 (± 16.7)
SD: standard deviation.
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DISCUSSION
The ROMP questionnaire is a simple, quick-to-apply 
and easy-to-understand instruction, and the scales of mea-
surements have remained the same as in the studies by 
Kalf et al.12 and Paulinelli et al.31. Its translation and adapta-
tion to Portuguese proved it to be a valid questionnaire in 
its content and reliability in quantifying difficulty in speak-
ing, swallowing and controlling of saliva in patients with PD. 
In the evaluation of linguistic equivalence, all the questions 
of the original version were retained in the Brazilian version, 
as none of the questions proved to be invalid. Only concep-
tual reformulations were carried out, modifying some terms 
aimed at a better cultural adaptation.
The internal consistency and test-retest reproducibility of 
the ROMP were much higher than 0.70, indicating a reliable ques-
tionnaire. This result was similar to the Parkinson’s disease ques-
tionnaire-39 item version32, and other questionnaires already 
validated in Brazil; those using the self-evaluation of voice, such 
as the Quality of Life in Voice, the Participation Profile and Vocal 
Activities and the Vocal Disadvantage Index12,31.
Besides it being very important to measure the aspects 
of the impact of speech, swallowing and saliva changes on 
the patient, to make the necessary referrals and to define the 
basis of the treatment, it may be valuable to compare these 
results with other scales27. In the case of this questionnaire, 
there was a significant difference in the correlation between 
all the questions between the ROMP and the Likert-type 
scale, the ROMP and the subscales of speech, salivation and 
swallowing in the UPDRS II and the subscale of speech in the 
UPDRS III. The ROMP was able to detect the clinical altera-
tions between these studied scales showing how much the 
protocol can differentiate the studied groups, assuring the 
reliability of the instrument. We observed that within a con-
textualized analysis of each patient, the ROMP questions 
were clinically useful and allowed a reliable evaluation on an 
individual level.
When analyzing the results of this questionnaire in rela-
tion to the others validated in Brazil, the usefulness, validity 
and practicality of using questionnaires to assess the impact 
of diseases on individuals’ perceptions can be seen again, 
especially when these questionnaires are specific to some 
change, such as, in this case, speech, swallowing and saliva 
changes. In addition to all these advantages, self-assessment 
shows us the point of view of the individual being treated, 
and not only the clinician’s view31,32.
Regarding the limitations of this study, since the patients 
evaluated were classified with H&Y 2 and H&Y 3, we hypoth-
esize that, if patients with H&Y 4 and 5 were evaluated, they 
might have presented with a higher degree of impairment, as 
scored by the questionnaire. Therefore, to detect these pos-
sible differences, research in patients with more severe dis-
ease involvement would be useful. Also, the results of this 
study justify the continuity of this research that has been 
expanded for validation of the ROMP construct in patients 
with Parkinson’s disease.
The importance of this study is focused on the fact that 
there are few self-assessment questionnaires that evalu-
ate speech, swallowing and saliva control in patients with 
PD. The patients’ self-perception of these changes con-
tribute to the accuracy of speech-language assessment, 
with implications for clinical practice and future research, 
which may contribute to a more accurate diagnosis and 
a more adequate therapeutic plan, improving communi-
cative effectiveness, swallowing and control of saliva for 
a longer time and, consequently, improving the quality of 
life of these patients.
In conclusion, the Brazilian Portuguese version of the 
ROMP questionnaire is reliable and valid and can be used in 
speech and language practice on an individual level. Its appli-
cation in patients with PD facilitates the identification of 
speech disorders, swallowing disorders and drooling in these 
patients, which is important for adequate referral, evaluation 
and timely rehabilitation.
Table 4. Intraclass Correlation Coefficient.
Variable Measures Intraclass correlationa
95%CI F Test with True Value 0 
Lower bound Upper bound Significance
Speech
Single 0.99b 0.99 0.99 0.00
Average 0.99c 0.99 1.00 0.00
Swallowing
Single 0.98b 0.97 0.99 0.00
Average 0.99c 0.98 0.99 0.00
Saliva
Single 0.93b 0.85 0.96 0.00
Average 0.96c 0.92 0.98 0.00
Total
Single 0.99b 0.99 0.99 0.00
Average 0.99c 0.99 0.99 0.00
Two-way mixed effects model where people effects are random and measures effects are fixed.
a: Type C intraclass correlation coefficients using a consistency definition – the between-measure variance is excluded from the denominator variance; b: The 
estimator is the same, whether the interaction effect is present or not; c: This estimate is computed assuming the interaction effect is absent, because it is not 
estimable otherwise. CI: confidence interval; Significance: (p ≤ 0.01).
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